User profiles for Michael E Johansen
 | michael johansenOhioHealth Verified email at ohiohealth.com Cited by 871 |
Gabapentinoid use in the United States 2002 through 2015
ME Johansen - JAMA internal medicine, 2018 - jamanetwork.com
Methods| The 2002-2015 Medical Expenditure Panel Survey (MEPS) was used for the analysis.
6 The MEPS is cosponsored by the Agency for Healthcare, Research, and Quality and …
6 The MEPS is cosponsored by the Agency for Healthcare, Research, and Quality and …
Cardiovascular risk and statin use in the United States
ME Johansen, LA Green, A Sen… - The Annals of Family …, 2014 - Annals Family Med
PURPOSE Statins reduce the risk of mortality and coronary artery disease in individuals at
high cardiovascular risk. Using nationally representative data, we examined the relationships …
high cardiovascular risk. Using nationally representative data, we examined the relationships …
Assessment of publication trends of systematic reviews and randomized clinical trials, 1995 to 2017
JD Niforatos, M Weaver, ME Johansen - JAMA Internal Medicine, 2019 - jamanetwork.com
Methods| We conducted a cross-sectional study of PubMedindexed SRMAs and RCTs
published from 1995 to 2017 using the UNIX terminal window Entrez Direct (EDirect). EDirect is …
published from 1995 to 2017 using the UNIX terminal window Entrez Direct (EDirect). EDirect is …
Lowering nighttime blood pressure with bedtime dosing of antihypertensive medications: controversies in hypertension-con side of the argument
Methods 3a Trial design Outcomes article, p3:“multicentre, controlled, PROBE (prospective,
randomized, open-label, blinded end point) study with patients distributed in a 1: 1 ratio into …
randomized, open-label, blinded end point) study with patients distributed in a 1: 1 ratio into …
Estimation of potential savings through therapeutic substitution
ME Johansen, C Richardson - JAMA internal medicine, 2016 - jamanetwork.com
Importance Therapeutic substitution offers potential to decrease pharmaceutical expenditures
and potentially improve the efficiency of the health care system. Objective To estimate …
and potentially improve the efficiency of the health care system. Objective To estimate …
Reexamining the ecology of medical care
ME Johansen, SM Kircher… - New England Journal of …, 2016 - Mass Medical Soc
In this analysis of data from the US Medical Expenditure Panel Survey, the overall frequency
of outpatient physician visits, emergency department visits, and inpatient hospitalizations did …
of outpatient physician visits, emergency department visits, and inpatient hospitalizations did …
The cardiovascular outcomes, heart failure and kidney disease trials tell that the time to use sodium glucose cotransporter 2 inhibitors is now
ME Johansen, C Argyropoulos - Clinical Cardiology, 2020 - Wiley Online Library
Sodium glucose contrasporter 2 inhibitors (SGLT2i) were initially introduced as a novel class
of modestly effective antiglycemics. Over the last 5 years, multiple members of this class …
of modestly effective antiglycemics. Over the last 5 years, multiple members of this class …
Antiplatelet and statin use in US patients with coronary artery disease categorized by race/ethnicity and gender, 2003 to 2012
Antiplatelets and statins are efficacious for preventing future cardiovascular events in
patients with coronary heart disease. Disparity in cardiovascular outcomes exists by race/ethnicity …
patients with coronary heart disease. Disparity in cardiovascular outcomes exists by race/ethnicity …
Statin use in very elderly individuals, 1999-2012
ME Johansen, LA Green - JAMA Internal Medicine, 2015 - jamanetwork.com
Methods| The 1999-2012 Medical Expenditure Panel Survey (MEPS) was used for the analysis.
4 The MEPS is nationally representative of the civilian noninstitutionalized population of …
4 The MEPS is nationally representative of the civilian noninstitutionalized population of …
Attention deficit hyperactivity disorder medication use among teens and young adults
ME Johansen, K Matic, AS McAlearney - Journal of Adolescent Health, 2015 - Elsevier
Purpose The purpose of this study was to determine rates of stimulant/atomoxetine use
among teens (aged 12–17 years) and young adults (aged 18–23 years) and to investigate …
among teens (aged 12–17 years) and young adults (aged 18–23 years) and to investigate …